Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease…
Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share Private Placement Up to $1.0 Million Intended to Support…
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical…
SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA…
Company Announcement COPENHAGEN, Denmark; February 20, 2026 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation…
February 20, 2026 09:05 ET | Source: Ernexa Therapeutics Inc. Live video webcast with Sanjeev Luther, President and Chief Executive…
February 20, 2026 09:00 ET | Source: Nokia Oyj Nokia CorporationManagers’ transactions20 February 2026 at 16:00 EETNokia Corporation - Managers'…
February 20, 2026 09:00 ET | Source: Nokia Oyj Nokia CorporationManagers’ transactions20 February 2026 at 16:00 EETNokia Corporation - Managers'…
Panel discussion will share insights on verification modernization, data transformation, and community engagement strategies at the 2026 State Healthcare IT…
NEEDHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical…